Articles

Creating a Navigation Program - Where to Begin
Beginning a navigation program can be intimidating, and there is no one program that fits every institution. Lillie recommends visiting other institutions that have established programs as a starting point. She also explains that practices need to look at their own operations management process in order to determine what will work best for their institution. Read More ›

Savvy Consumers Appreciate NCI Designation
Although it is no small task, Lillie explains that achieving the Commission on Cancer Accreditation is important and offers the benefit of becoming an NCI-designated cancer center. This is something savvy consumers are looking for when seeking cancer care. Read More ›

Marketing Troubles for Nonaccredited Practices
Lillie discusses the disadvantages for institutions that are not Commission on Cancer accredited, including difficulties drawing newly diagnosed consumers and referring physicians to the practice. The accreditation requires the practice to meet certain standards that are important to cancer care and survivorship. Read More ›

AONN+ Provides Resource for Establishing Navigation Programs
In addition to visiting other institutions that have established navigation programs, Lillie explains that AONN+ is an excellent resource for establishing navigation programs. As a professional organization with a membership of navigators, they have information about how to train navigators, how to continue education, and what new resources are available to break barriers. Read More ›

The Oncology Nurse-APN/PA spoke with Laura Zitella, MS, RN, ACNP-BC, AOCN, Lead Advanced Practice Provider (APP)/Nurse Practitioner (NP) for Inpatient Hematology/Oncology about her role at SHC and her experience there. Read More ›

The Third Annual World Cutaneous Malignancies Congress (WCMC) took place in San Francisco, California, in October 2014. Read More ›

On the front lines of the war on cancer, nurses are often the field commanders—in charge of safely navigating patients through treacherous terrain as well as delivering medical treatment that should provide maximal health benefits and minimize adverse effects. Read More ›

Patients with a cancer diagnosis endure multiple complications and stresses, particularly when disease progresses. Unfortunately, the treatments themselves can also result in debilitating side effects that further increase their suffering. Read More ›

In this issue of The Oncology Nurse-APN/PA, we offer a selection of topics that we hope you will find useful in your daily practice as you care for patients with cancer. Read More ›

Results of a phase 3 study of an investigational monoclonal antibody, MABp1 (Xilonix; XBiotech), evaluated for cachexia in metastatic colorectal cancer (CRC), revealed a surprising finding: patients in the experimental arm showed a trend toward increased overall survival (an end point difficult to reach in any treatment-refractory cancer), with pharmacodynamics activity consistent with this result, investigators reported at the 2015 Gastrointestinal Cancers Symposium, held in San Francisco, California. Read More ›

Page 219 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: